Advanced Biomed Common Key Fundamental And Technical Indicators
| ADVB Stock | 6.78 -0.08 -1.17% |
Momentum
OversoldOverbought
59 · Buy Extended
As of the 7th of May, Advanced Biomed reports 6.78 per share in the latest quote. Technical drivers report Downside Deviation of 7.72, mean deviation of 5.39, and Risk Adjusted Performance of 0.1074. Price momentum and volatility relationships form the basis of the analysis. Cross-sectional analysis places indicator values in market context.
Advanced Biomed discloses its performance through quarterly and annual statements used to model future cash flows. Performance benchmarked against historical norms is reflected in the key metrics below:Advanced Biomed Common does not currently have any fundamental trend indicators for analysis. For wider market screening beyond Advanced Biomed, explore the Equity Screeners module. Available filters include financial, valuation, and market-based dimensions.Advanced Biomed's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives and major shareholders may have access to non-public information about a firm's operations that is not available to the general public.
Insiders Shares | = | Executives Shares | + | Employees |
Current Advanced Biomed Shares Owned By Insiders | 55.00 % |
Ratios like Shares Owned By Insiders help investors see if Advanced Biomed's market price truly reflects the company's real worth. The link between Advanced Biomed's core metrics and market price helps shape the investment case. Growth hopes can justify a higher valuation, but only if future earnings are likely to come through. These findings merit weighing with other tools before making investment choices. A price-to-book ratio of 0.76 helps frame the market's assessment of Advanced Biomed's asset base.
| Competition |
Advanced Biomed Common Fundamental Drivers Relationships
Main Technical Indicators as of May 7, 2026
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1074 | |||
| Market Risk Adjusted Performance | -2.58 | |||
| Mean Deviation | 5.39 | |||
| Semi Deviation | 6.79 | |||
| Downside Deviation | 7.72 | |||
| Coefficient Of Variation | 979.33 | |||
| Standard Deviation | 9.16 | |||
| Variance | 83.88 | |||
| Information Ratio | 0.0999 | |||
| Jensen Alpha | 0.9287 | |||
| Total Risk Alpha | 0.8311 | |||
| Sortino Ratio | 0.1185 | |||
| Treynor Ratio | -2.59 | |||
| Maximum Drawdown | 70.58 | |||
| Value At Risk | -11.44 | |||
| Potential Upside | 13.09 | |||
| Downside Variance | 59.64 | |||
| Semi Variance | 46.08 | |||
| Expected Short fall | -6.05 | |||
| Skewness | 1.92 | |||
| Kurtosis | 10.7 |
Daily Market Strength Indicators
For investors tracking Advanced Biomed Common, market strength indicators offer quantitative evaluation of stock behavior. When Rate of Change diverges from price direction, it often signals weakening momentum before a visible reversal in Advanced Biomed.
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 6.78 | |||
| Day Typical Price | 6.78 | |||
| Price Action Indicator | -0.04 | |||
| Period Momentum Indicator | -0.08 | |||
| Relative Strength Index | 59.79 |
Basic Forecasting Models
Volume-weighted price analysis for Advanced Biomed Stock gives heavier weight to price levels where trading activity was highest. Crossovers in the MACD line and signal line identify shifts in Advanced Biomed momentum before they appear in raw price.Advanced Biomed Related Equities
Investors studying Advanced Biomed often look at related stocks within the Health Care space to gauge pricing and results. Revenue and margin checks across this group help investors set expectations for Advanced Biomed's results.
| Risk & Return | Correlation |
Shares Owned By Insiders Peer Comparison
Peer comparison of Advanced Biomed using Shares Owned By Insiders provides a quantitative benchmark against similar stocks. Identifying gaps in Advanced Biomed's Shares Owned By Insiders relative to peers supports more targeted investment analysis.Advanced Biomed is currently under evaluation in shares owned by insiders among leading competitors.
Important Fundamentals
| Return On Equity TTM | 0.8 | |||
| Return On Asset TTM | -0.27 | |||
| Current Valuation | 4.61 M | |||
| Shares Outstanding | 1.36 M | |||
| Shares Owned By Insiders | 55.00 % | |||
| Shares Owned By Institutions | 0.16 % | |||
| Number Of Shares Shorted | 49.19 K | |||
| Price To Book TTM | 0.76 X | |||
| EBITDA TTM | -90.81 K | |||
| Net Income TTM | -101.52 K | |||
| Total Debt TTM | 1.26 M | |||
| Book Value Per Share TTM | 8.76 X | |||
| Cash Flow From Operations TTM | -181.46 K | |||
| Short Ratio TTM | 0.05 X | |||
| Earnings Per Share | 4.22 X | |||
| Number Of Employees | 31 | |||
| Market Capitalization TTM | 8.13 M | |||
| Total Asset TTM | 6.51 B | |||
| Retained Earnings TTM | -19.23 B | |||
| Working Capital TTM | 318.65 K | |||
| Net Asset | 6.51 B |
Financial Metrics, Fundamentals & Methodology
Advanced Biomed's operating framework helps explain margin behavior, earnings persistence, and funding capacity. Capital intensity is provided as a reference for reinvestment requirements. In recent filings, Advanced Biomed reported positive EPS of 4.22 as of the latest reporting period.
Advanced Biomed Common data is compiled from periodic company reporting and market reference feeds and standardized for comparability. Statement-level metrics reflect company-reported GAAP or IFRS formats for the relevant filing period.
Editorial review and methodology oversight provided by: Ellen Johnson, Member of Macroaxis Editorial Board